1. Home
  2. Dipeptidyl peptidase-4 inhibitor
  Subject:

Dipeptidyl peptidase-4 inhibitor   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Diabetes mellitus type 2  9 times
Dipeptidyl peptidase-4  7 times
Sitagliptin  5 times
Enzyme inhibitor  5 times
Metformin  4 times
Hypoglycemia  4 times
Blood plasma  4 times
Placebo  3 times
Hyperglycemia  3 times
Pioglitazone  2 times
Insulin  2 times
Clinical trial  2 times
Carboxylic acid  2 times
Blood sugar  2 times
Thiourea  1 time
The Control Group  1 time
Stromal cell-derived factor 1  1 time
Stroke  1 time
Striatum  1 time
Standard deviation  1 time
Single Center  1 time
Serotonin  1 time
SGLT2  1 time
Renal function  1 time
Race and ethnicity in the United States Census  1 time
Pharmacokinetics  1 time
Peroxisome proliferator-activated receptor  1 time
Peripheral artery disease  1 time
Percutaneous coronary intervention  1 time
Peptide  1 time
Pancreatic cancer  1 time
Nitrogen  1 time
Metabolite  1 time
Metabolism  1 time
Low-density lipoprotein  1 time
Lipoprotein  1 time
Japan  1 time
Infarction  1 time
India  1 time
IC50  1 time
Hypothalamus  1 time
Hypertension  1 time
High-performance liquid chromatography  1 time
Hemoglobin  1 time
Glycated hemoglobin  1 time
Glucagon  1 time
Glibenclamide  1 time
Gastric acid  1 time
Fasting  1 time
Enzyme  1 time
Dyslipidemia  1 time
Dopamine  1 time
Confidence interval  1 time
ClinicalTrials.gov  1 time
Chronic obstructive pulmonary disease  1 time
Cerebrovascular disease  1 time
Cell surface receptor  1 time
CD34  1 time
CD133  1 time
Body mass index  1 time
Bladder cancer  1 time
Bioavailability  1 time
Artificial intelligence  1 time
Apolipoprotein  1 time
Anti-diabetic medication  1 time
Amygdala  1 time
Adiponectin  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

2. Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients

3. Effect of antihyperglycemic drug monotherapy to prevent the progression of mild hyperglycemia in early type 2 diabetic patients: the Japan Early Diabetes Intervention Study (JEDIS)

4. Sitagliptin: A Review in Type 2 Diabetes

5. Dipeptidyl Peptidase 4 Inhibitors Diprotin A and Sitagliptin Administered on Weeks 2-3 of Postnatal Development Modulate Monoamine Metabolism in the Striatum of Adult Rats

6. Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials

7. New dipeptidyl peptidase 4 inhibitors among adamantane derivatives

8. Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

9. The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction

10. A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control

11. A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?

12. The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

13. Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes


Questions?

Drop us a message.